Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ER Y537S
i
Other names:
ESR1, Era, ESR, NR3A1, ER, ER beta
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2099
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
ER positive (198)
HR positive (184)
HR negative (25)
ER negative (13)
ER positive + PGR positive (12)
HR positive + HER-2 negative (5)
ER expression (3)
ER overexpression (3)
IRF8 overexpression + ER negative (3)
ER positive + HER-2 negative (2)
ER positive + PGR negative (2)
FGFR1 overexpression + HR positive (2)
HR negative + PD-L1 expression (2)
HR positive + ER overexpression (2)
HR positive + HER-2 underexpression (2)
AR positive + ER positive (1)
CETN2 overexpression + HR positive (1)
CETN2 overexpression + MLH3 overexpression + PCNA overexpression + HR positive (1)
CTSD positive + ER positive (1)
ER negative + HER-2 negative (1)
ER positive + CDK6 overexpression (1)
ER positive + PGR negative + HER-2 negative (1)
ER underexpression (1)
HDC overexpression + HR positive (1)
HER-2 underexpression + ER underexpression (1)
HR overexpression (1)
HR positive + AR positive (1)
HR positive + BRCA positive (1)
HR positive + CCNE1 overexpression (1)
HR positive + ERBB3 overexpression (1)
HR positive + ERBB3 underexpression (1)
HR positive + HER-2 positive (1)
HR positive + PD-L1 expression (1)
HR positive + PLK1 overexpression (1)
HR positive + TNFRSF11A overexpression (1)
MLH3 overexpression + HR positive (1)
NOTCH3 expression + ER positive + PGR positive (1)
PCNA overexpression + HR positive (1)
PD-L1 overexpression + ER positive (1)
RAD51 overexpression + HR positive (1)
RFC3 overexpression + ER positive (1)
TFF1 overexpression + ER positive (1)
TFF3 overexpression + ER positive (1)
TNFRSF1A overexpression + HR positive (1)
TYMS overexpression + HR positive (1)
BIN3 expression + ER positive (0)
CCNA2 expression + ER positive (0)
CCNB2 expression + ER positive (0)
CTDSP1 expression + ER positive (0)
EPRS1 expression + ER positive (0)
ER negative + HER-2 positive (0)
ER negative + PGR positive (0)
ER positive + HER-2 positive (0)
ER positive + PGR positive + HER-2 positive (0)
FOXD1 expression + ER positive (0)
FTO expression + ER positive (0)
HR negative + HER-2 positive (0)
MIEN1 expression + ER negative + PR negative (0)
NCOR2 overexpression + ER positive (0)
RBPMS expression + ER positive (0)
SLBP expression + ER positive (0)
WSB2 expression + ER positive (0)
ER positive (198)
HR positive (184)
HR negative (25)
ER negative (13)
ER positive + PGR positive (12)
HR positive + HER-2 negative (5)
ER expression (3)
ER overexpression (3)
IRF8 overexpression + ER negative (3)
ER positive + HER-2 negative (2)
ER positive + PGR negative (2)
FGFR1 overexpression + HR positive (2)
HR negative + PD-L1 expression (2)
HR positive + ER overexpression (2)
HR positive + HER-2 underexpression (2)
AR positive + ER positive (1)
CETN2 overexpression + HR positive (1)
CETN2 overexpression + MLH3 overexpression + PCNA overexpression + HR positive (1)
CTSD positive + ER positive (1)
ER negative + HER-2 negative (1)
ER positive + CDK6 overexpression (1)
ER positive + PGR negative + HER-2 negative (1)
ER underexpression (1)
HDC overexpression + HR positive (1)
HER-2 underexpression + ER underexpression (1)
HR overexpression (1)
HR positive + AR positive (1)
HR positive + BRCA positive (1)
HR positive + CCNE1 overexpression (1)
HR positive + ERBB3 overexpression (1)
HR positive + ERBB3 underexpression (1)
HR positive + HER-2 positive (1)
HR positive + PD-L1 expression (1)
HR positive + PLK1 overexpression (1)
HR positive + TNFRSF11A overexpression (1)
MLH3 overexpression + HR positive (1)
NOTCH3 expression + ER positive + PGR positive (1)
PCNA overexpression + HR positive (1)
PD-L1 overexpression + ER positive (1)
RAD51 overexpression + HR positive (1)
RFC3 overexpression + ER positive (1)
TFF1 overexpression + ER positive (1)
TFF3 overexpression + ER positive (1)
TNFRSF1A overexpression + HR positive (1)
TYMS overexpression + HR positive (1)
BIN3 expression + ER positive (0)
CCNA2 expression + ER positive (0)
CCNB2 expression + ER positive (0)
CTDSP1 expression + ER positive (0)
EPRS1 expression + ER positive (0)
ER negative + HER-2 positive (0)
ER negative + PGR positive (0)
ER positive + HER-2 positive (0)
ER positive + PGR positive + HER-2 positive (0)
FOXD1 expression + ER positive (0)
FTO expression + ER positive (0)
HR negative + HER-2 positive (0)
MIEN1 expression + ER negative + PR negative (0)
NCOR2 overexpression + ER positive (0)
RBPMS expression + ER positive (0)
SLBP expression + ER positive (0)
WSB2 expression + ER positive (0)
›
Associations
(17)
News
Trials
Search handles
@LGerratana
Search handles
@LGerratana
Filter by
Latest
1year
New data supporting a deeper #ESR1 variant characterization in #BreastCancer. Y537S is resistant to #SERD #SERM due to stable conformation and activity. L536 shows varying sensitivity, greatest resistance: AZD9833 GDC-0810 RAD1901 #PrecisionMedicine #bcsm https://t.co/5llI1gngbs (@LGerratana)
1 year ago
ER (Estrogen receptor)
|
ER Y537S
|
Orserdu (elacestrant) • camizestrant (AZD9833) • brilanestrant (GDC-0810)
2years
If you have ER+ metastatic breast cancer with an ESR1 mutation Y537S, @CancerCenter this phase I/2 trial offers a new oral selective estrogen receptor covalent antagonist (no more than 1 prior line of chemo) https://t.co/dTCNw4Cl3w. @ErikaHamilton9 (@eugeneahn)
2 years ago
ER (Estrogen receptor)
|
ER mutation • ER Y537S • ESR1 mutation
almost3years
In the phase 2, stable disease was seen in 43% of people and a partial response in 17%. Those with the Y537S ESR1 mutation had the highest clinical benefit rate, although those with D538G also showed some benefit. #ASCO21 #bcsm (@stage4kelly)
almost 3 years ago
Clinical • P2 data
|
ER (Estrogen receptor)
|
ER mutation • ER Y537S • ER D538G
over3years
H3B-6545はESR1 Y537S変異やCDK4/6阻害薬・フルベストラントを含む治療歴の多いER+HER2-転移乳癌に対し有望【SABCS2020】:がんナビ サンアントニオ乳がんシンポジウムからのニュースです。今後の開発に期待します。 #乳がん #SABCS20 https://t.co/2VkXfo0c3i (@cancer_navi)
over 3 years ago
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • CDK4 (Cyclin-dependent kinase 4)
|
ER Y537S
|
H3B-6545
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login